HEALTH PROFESSIONAL · SOURCE READING
Osteosarcoma of the Head and Neck
Source: Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 2, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Localized Osteosarcoma and UPS of Bone
Osteosarcoma of the head and neck occurs in an older population than does osteosarcoma of the extremities.[48,51-54] In the pediatric age group, osteosarcomas of the head and neck are more likely to be low-grade or intermediate-grade tumors than are osteosarcomas of the extremities.[55,56] All reported series emphasize the need for complete surgical resection.[48,51-56][Level of evidence C1] The probability for cure with surgery alone is higher for osteosarcoma of the head and neck than it is for extremity osteosarcoma. When surgical margins are positive, there is a trend for improved survival with adjuvant radiation therapy.[48,53][Level of evidence C1]
There are no randomized trials to assess the efficacy of chemotherapy in patients with osteosarcoma of the head and neck, but several series suggest a benefit.[51,57] Chemotherapy should be considered for younger patients with high-grade osteosarcoma of the head and neck.[55,58]
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice
Triangle